Polycythemia
Showing 1 - 25 of 386
Effect of Phlebotomy on Heartrate in Polycythemia Patients
Not yet recruiting
- Polycythemia
- phlebotomy
- (no location specified)
Jun 2, 2022
Identify and Describe Predictive Factors for Thromboembolic
Not yet recruiting
- Polycythemia Vera
- Hydroxyurea
- Ruxolitinib
- (no location specified)
Sep 21, 2022
Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))
Not yet recruiting
- Polycythemia Vera
- Ropeginterferon alfa-2b-njft (P1101)
- (no location specified)
Jul 28, 2022
Ruxolitinib for Polycythemia Vera in Patients Resistant to or
Completed
- Polycythemia Vera (PV)
- Ruxolitinib
-
East Hanover, New JerseyNovartis Investigative Site
Jun 29, 2022
Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Polycythemia Vera
-
Phoenix, Arizona
- +4 more
Jun 20, 2022
Phlebotomy Dependent Polycythemia Vera Trial in Canada, United Kingdom, United States (IONIS-TMPRSS6-LRx)
Recruiting
- Phlebotomy Dependent Polycythemia Vera
-
Orange, California
- +4 more
Aug 1, 2022
Polycythemia Vera, Essential Thrombocythemia, and
Not yet recruiting
- Myeloproliferative Neoplasm
- Next-generation sequencing
- (no location specified)
Jun 27, 2022
Molecular Biology of Polycythemia and Thrombocytosis
Recruiting
- Polycythemia
- Thrombocytosis
-
Salt Lake City, UtahUniversity of Utah
Oct 29, 2021
Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,
Recruiting
- Primary Myelofibrosis
- +2 more
- NS-018
- Best Available Therapy
-
Ipoh, Perak, MalaysiaHospital Raja Permaisuri Bainun
Jul 18, 2022
Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)
Recruiting
- Primary Myelofibrosis
- +4 more
-
New York, New YorkRuttenberg Treatment Center
Jul 18, 2022
Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)
Recruiting
- Myelofibrosis Due to and Following Polycythemia Vera
-
Basking Ridge, New Jersey
- +6 more
Jan 26, 2023
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)
Active, not recruiting
- Myeloproliferative Neoplasm
- +4 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Jan 20, 2022
Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))
Recruiting
- Polycythemia Vera (PV)
- P1101 (Ropeginterferon alfa-2b)
-
Toon-shi, Ehime, Japan
- +5 more
Jun 13, 2022